Skip to main content

Global Drug Eluting Balloon Market Growth Accelerated By Increasing Prevalence Of Cardiovascular Diseases

Drug Eluting Balloon Market

Drug eluting balloon catheters are medical balloon catheters that are coated with medication and are used to widen blocked or narrow arteries during percutaneous coronary intervention. Drug eluting balloons help prevent renarrowing of arteries by slowly releasing drugs like paclitaxel directly into the artery walls. The demand for drug eluting balloons is rising mainly due to the increasing prevalence of cardiovascular diseases globally.

The global drug eluting balloon market is estimated to be valued at US$ 667.78 Mn in 2023 and is expected to exhibit a CAGR of 13 % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The increasing prevalence of cardiovascular diseases is one of the key trends driving the growth of the drug eluting balloon market. Cardiovascular diseases are the leading cause of death globally. According to the World Health Organization, cardiovascular diseases cause over 17.9 million deaths worldwide every year. Conditions like coronary artery disease, cardiac arrhythmias, heart failure etc. are increasing at an alarming rate globally due to changing lifestyles, rising stress levels and increasing geriatric population. Drug eluting balloons help treat many cardiovascular conditions effectively and hence their demand is growing significantly with the increasing burden of cardiovascular diseases. The higher efficacy of drug eluting balloons compared to plain old balloons and stents is also fueling their adoption rate globally.

Segment Analysis

The global drug eluting balloon market is dominated by the peripheral drug eluting balloon segment. This segment accounted for the largest revenue share in 2022, owing to the increasing prevalence of peripheral artery diseases such as peripheral vascular diseases. Peripheral drug eluting balloons are used to treat blockages in leg arteries, thus experiencing high demand.

Key Takeaways

The Global Drug Eluting Balloon Market Size is expected to witness high growth during the forecast period of 2023 to 2030. The global drug eluting balloon market is estimated to be valued at US$ 667.78 Mn in 2023 and is expected to exhibit a CAGR of 13 % over the forecast period 2023 to 2030.

Regional analysis shows that Asia Pacific region is fastest growing regional market and is expected to dominate the market during the forecast period. Increasing incidence of cardiovascular diseases along with rising healthcare spending in developing countries such as China and India is fueling the growth of drug eluting balloon market in Asia Pacific.

Key players operating in the drug eluting balloon market are Cato Manufacturing Ltd, Culver Props, Inc., Delta Electronics, Inc., Dowty Circuits Limited, Hartzell Propeller, Inc., McCauley Propeller Systems, Inc., and others. The market players are focusing on new product launches and expansion of regional presence to strengthen their market position. For instance, in 2022, Medtronic launched the IN.PACT AV drug-coated balloon for treating blocked arteries in the leg.

Explore more information on this topic, Please visit -

https://www.insightprobing.com/drug-eluting-balloon-market-growth-and-forecasts-analysis/

Comments

Popular posts from this blog

Rails to Resilience: Strategies Driving Growth in the Railway Coatings Market

Railway Coatings Market Railway coatings play a critical role in protecting rail infrastructure against corrosion, abrasion, and weathering, thereby extending the lifespan of railway assets and enhancing operational efficiency. The Railway Coatings Market encompasses a diverse range of coatings specifically formulated to meet the unique requirements of rail applications, including coatings for rolling stock, track components, bridges, and stations. As the global rail industry continues to expand and modernize, the demand for high-performance coatings that offer durability, safety, and environmental sustainability is on the rise. The railway coatings market was valued at  US$ 2,334.2 Mn in 2024 , and is expected to exhibit a  CAGR of 5.2% , in terms of revenue, over the forecast period  2024-2031  to reach  US$ 3,497.6 Mn by 2031 . Key Takeaways: The Railway Coatings Market is witnessing steady growth, driven by various factors such as infrastructure development ...

Sustainable Aviation Fuel Market is Set to Witness Significant Growth Due to Stringent Emission Norms

Sustainable Aviation Fuel Market Sustainable aviation fuel, also known as biofuel, refers to jet fuel produced from sustainable feedstocks such as grease, vegetable oils and animal fats. It is mandated to reduce the environmental impact of aviation, with a life cycle carbon footprint up to 80% lower than conventional jet fuel. Governments across regions are adopting policies and targets to promote sustainable aviation fuel uptake among airlines. For instance, the EU aims to reach 2 million tons of sustainable fuel per year by 2030. The global sustainable aviation fuel market is estimated to be valued at US$ 2.37 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the sustainable aviation fuel are Eisai Co., Ltd., Novartis AG, AbbVie Inc. (Allergan Plc.), Adamas Pharmaceuticals, Inc., H. Lundbeck A/S, Biogen, AC Immune, F. Hoffmann La Roche Ltd., Daiichi Sankyo Company, Limited, Johnson & Johnson Services,...

The Global Antifoaming Agent Market is poised to Exhibit Strong Growth

Antifoaming Agent Market The antifoaming agent market is fast gaining traction due to increasing industrial usage of chemicals, especially in numerous end-use sectors like pharmaceuticals, pulp & paper, paints & coatings, oil & gas, and food & beverages. Antifoaming agents are chemicals that reduce or suppress the formation of foam in industrial processes. They are widely used as additives to prevent foaming issues in various industrial applications. Commonly used antifoaming agents include silicone-based, oil-based, and water-based defoamers. These agents find usage in processes involving agitation to prevent excessive foaming that can negatively impact manufacturing operations and product quality. The Global Antifoaming Agent Market is estimated to be valued at US$ 6.08 Bn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Global Antifoaming Agent market are BASF, Evonik Industries, Air P...